Abstract
Liver fluke Fasciola hepatica remains an important agent of foodborne trematode disease producing great economic losses due to its negative effect on productivity of grazing livestock in temperate areas. The prevailing control strategies based on antihelminthic drugs are not long term sustainable due to widespread resistance. Hence, vaccination appears as an attractive option to pursue for parasite eradication.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO (2018) Neglected tropical diseases. Human fascioliasis: review provides fresh perspectives on infection and control. who.int/foodborne_trematode_infections/fascioliasis/en/
Carmona C, Tort JF (2017) Fasciolosis in South America: epidemiology and control challenges. J Helminthol 91(2):99–109. https://doi.org/10.1017/S0022149X16000560
Spithill TW, Smooker PM, Copeman DB (1999) Fasciola gigantica: epidemiology, control, immunology and molecular biology. In: Dalton JP (ed) Fasciolosis. CAB International Publishing, Wallingford, Oxon, pp 377–410
Schweizer G, Braun U, Deplazes P, Torgerson PR (2005) Estimating the financial losses due to bovine fasciolosis in Switzerland. Vet Rec 157:188–193
Kaplan RM (2001) Fasciola hepatica: a review of the economic impact in cattle and considerations for control. Vet Ther 2(1):40–50
Charlier J, Vercruysse J, Morgan E, van Dijk J, Williams DJ (2014) Recent advances in the diagnosis, impact on production and prediction of Fasciola hepatica in cattle. Parasitology 141(3):326–335. https://doi.org/10.1017/S0031182013001662
Andrews S (1999) In: Dalton JP (ed) The life cycle of Faciola hepatica. En: Fasciolosis. CAB International, Wallingford, pp 1–20
Hatschbach PJ (1995). A Fasciola hepatica a sua historia. A Hora Vet (Ed.Extra) 15 (1): 10–11
Fairweather I, Boray JC (1999) Fasciolicides: efficacy, actions, resistance and its management. Vet J 158(2):81–112
Brennan GP, Fairweather I, Trudgett A, Hoey E et al (2007) Understanding triclabendazole resistance. Exp Mol Pathol 82(2):104–109
Fairweather I (2011) Liverfluke isolates: a question of provenance. Vet Parasitol 176:1–8
Kelley JM, Elliott TP, Beddoe T, Anderson G, Skuce P, Spithill TW (2016) Current threat of triclabendazole resistance in Fasciola hepatica. Trends Parasitol 32:458–469
Toet H, Piedrafita DM, Spithill TW (2014) Liver fluke vaccines in ruminants: strategies, progress and future opportunities. Int J Parasitol 44:915–927
Imperiale F, Ortiz P, Cabrera M, Farias C, Sallovitz JM, Iezzi S, Pérez J, Alvarez L, Lanusse C (2011) Residual concentrations of the flukicidal compound triclabendazole in dairy cows’ milk and cheese. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 28(4):438–445. https://doi.org/10.1080/19440049.2010.551422
Molina-Hernández V, Mulcahy G, Pérez J, Martínez-Moreno A, Donnelly S, O’Neill S, Daltona JP, Cwiklinski K (2015) Fasciola hepatica vaccine: we may not be there yet but we’re on the right road. Vet Parasitol 208:101–111
Beesley NJ, Caminade C, Charlier J, Flynn RJ, Hodgkinson JE, Martinez-Moreno A, Martinez-Valladares M, Perez J, Rinaldi L, Williams DJL (2018) Fasciola and fasciolosis in ruminants in Europe: identifying research needs. Transbound Emerg Dis 65(Suppl 1):199–216. https://doi.org/10.1111/tbed.12682
Dalton JP (1999) Fasciolosis. CABI Pub, Wallingford
Calvani NED, George SD, Windsor PA, Bush RD, Šlapeta J (2018) Comparison of early detection of Fasciola hepatica in experimentally infected merino sheep by real-time PCR, coproantigen ELISA and sedimentation. Vet Parasitol 251:85–89. https://doi.org/10.1016/j.vetpar.2018.01.004
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Maggioli, G., Salazar, C., Fossa, F., Carmona, C. (2020). Liver Fluke Vaccine Assessment in Cattle. In: Cancela, M., Maggioli, G. (eds) Fasciola hepatica. Methods in Molecular Biology, vol 2137. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0475-5_15
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0475-5_15
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0474-8
Online ISBN: 978-1-0716-0475-5
eBook Packages: Springer Protocols